This proposal describes the synthesis of a general class of nanoparticle delivery vectors based upon hybrid biomolecule-gold nanoparticle complexes. The vectors are designed to transport therapeutic oligonucleotides across cell membranes to target cancer cell nuclei. Therapeutic oligonucleotides are synthetic single stranded nucleic acid molecules that are resistant to digestion by nucleases. A multifunctional approach has been developed which combines cell-specific recognition ligands, endosomal escape peptides, nuclear localization signals and controlled release of therapeutic oligonucleotides to cells. The ability to target biomolecule-nanoparticle complexes to specific cell types, through a relatively simple attachment of cell-specific ligands or peptides, provides the potential for diagnosis and treatment of cancer. A quantitative test for nuclear delivery of an oligonucleotide drug to the nuclei of HeLa cells is proposed as an assay for the efficiency of delivery of a therapeutic agent. The long term goal of this research is to develop a non-viral vector capable of delivering therapeutic oligonucleotides to cancer cells in vivo. Achieving this long term goal requires the following steps. 1. Formulate stable nanoparticle-bioconjugates that are resistant to aggregation and chemical exchange in biological fluids and cells. 2. Develop microscopy techniques to monitor nanoparticle trajectories and quantitate localization in cells. 3. identify the best combination of peptides for performing the functions of endocytosis, endosomal escape and nuclear uptake. 4. Characterize fundamental interactions of protein-peptide conjugates with nanoparticles including their susceptibility to exchange or replacement. 5. Develop strategies for covalent attachment of proteins and oligonucleotides to nanoparticles. 6. Determine of the efficiency of regulated in vitro protein expression using a well-characterized model system.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA098194-03
Application #
6894244
Study Section
Special Emphasis Panel (ZRG1-BECM (01))
Program Officer
Fu, Yali
Project Start
2003-06-01
Project End
2007-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
3
Fiscal Year
2005
Total Cost
$275,472
Indirect Cost
Name
North Carolina State University Raleigh
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
042092122
City
Raleigh
State
NC
Country
United States
Zip Code
27695
Loo, LiNa; Guenther, Richard H; Lommel, Steven A et al. (2008) Infusion of dye molecules into Red clover necrotic mosaic virus. Chem Commun (Camb) :88-90
Liu, Yanli; Franzen, Stefan (2008) Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles. Bioconjug Chem 19:1009-16
Ryan, Joseph A; Overton, K Wesley; Speight, Molly E et al. (2007) Cellular uptake of gold nanoparticles passivated with BSA-SV40 large T antigen conjugates. Anal Chem 79:9150-9
Loo, LiNa; Guenther, Richard H; Lommel, Steven A et al. (2007) Encapsidation of nanoparticles by red clover necrotic mosaic virus. J Am Chem Soc 129:11111-7
Liu, Yanli; Shipton, Mathew K; Ryan, Joseph et al. (2007) Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. Anal Chem 79:2221-9
Agbasi-Porter, Chiamaka; Ryman-Rasmussen, Jessica; Franzen, Stefan et al. (2006) Transcription inhibition using oligonucleotide-modified gold nanoparticles. Bioconjug Chem 17:1178-83
Zeng, Wei; Eric Ballard, T; Tkachenko, Alexander G et al. (2006) Mimicking the biological activity of diazobenzo[b]fluorene natural products with electronically tuned diazofluorene analogs. Bioorg Med Chem Lett 16:5148-51
Tkachenko, Alexander G; Xie, Huan; Liu, Yanli et al. (2004) Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem 15:482-90